PIEL - ETF AI Analysis
Top Page
Pacer International Export Leaders ETF (PIEL)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Semiconductor Leaders
Top holdings like ASML and Tokyo Electron have shown strong year-to-date performance, helping drive the ETF’s returns.
Global Diversification
The fund spreads its investments across many countries, including the U.S., Europe, and Asia, which can reduce reliance on any single market.
Balanced Sector Mix
Exposure to general industries, health care, technology, and materials provides a mix of defensive and growth sectors that can smooth out performance over time.
Negative Factors
Moderately High Fees
The expense ratio is on the higher side for an ETF, which means more of the fund’s returns are used to cover costs.
Weakness in Some Major Holdings
Large positions such as LVMH and AstraZeneca have shown weaker recent performance, which can drag on the fund’s overall results.
Concentration in a Few Key Stocks
A small number of companies make up a meaningful portion of the portfolio, increasing the impact if any of these holdings run into trouble.
PIEL vs. SPDR S&P 500 ETF (SPY)
AUM1.13M
RegionGlobal Ex-U.S.
Expense Ratio0.60%
Beta1.36
IssuerPacer
Inception DateDec 23, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedPacer International Export Leaders Index - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume295
30 Day Avg. Volume523
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
35.99Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PIEL Summary
The Pacer International Export Leaders ETF (PIEL) follows the Pacer International Export Leaders Index, focusing on large and mid-sized companies outside the U.S. that earn a big share of their money from selling products around the world. It holds well-known global names like ASML, Nestlé, LVMH, Novartis, and AstraZeneca, across sectors such as technology, health care, and consumer goods. Someone might invest in PIEL to diversify beyond the U.S. and tap into growth from international trade and global brands. A key risk is that its value can rise or fall with overseas markets and currency swings, so returns may be more volatile than a U.S.-only fund.
How much will it cost me?This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is more specialized and rules-based in how it selects international export-focused companies.
What would affect this ETF?This ETF could benefit if global economic growth and trade pick up, boosting demand for exports from large non-U.S. companies, especially in technology, health care, and luxury consumer brands like ASML, Novartis, and LVMH. On the negative side, it could be hurt by global recessions, trade tensions, stronger regulations on drug and tech firms, or weaker consumer spending that would pressure cyclical and export-focused businesses.
PIEL Top 10 Holdings
PIEL leans heavily on a global cast of export powerhouses, with semiconductor leaders ASML and SK hynix doing much of the heavy lifting; ASML has been steadily rising over the year, while SK hynix has surged despite some recent wobbling. Big European pharma names like Novartis and Roche are providing a steady backbone, offsetting weakness from AstraZeneca, which has been losing steam. Luxury giants LVMH and Hermès, along with consumer staple Nestlé, have been more of a drag lately. Overall, the fund is concentrated in non-U.S. tech, healthcare, and European consumer brands.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 5.40% | $60.47K | €597.04B | 127.48% | 76 Outperform | |
| SK hynix Inc. | 4.61% | $51.59K | ₩10.00T> | 593.13% | ― | |
| Novartis AG | 4.42% | $49.52K | CHF231.67B | 37.69% | 80 Outperform | |
| Roche Holding AG | 4.27% | $47.78K | $345.58B | 34.54% | 73 Outperform | |
| Samsung Electronics | 4.08% | $45.60K | ₩10.00T> | 230.73% | ― | |
| AstraZeneca | 3.67% | $41.03K | $261.19B | 19.44% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 3.61% | $40.45K | €227.88B | -5.96% | 78 Outperform | |
| Nestlé SA | 3.54% | $39.57K | CHF207.50B | 6.66% | 71 Outperform | |
| BHP Group Ltd | 2.94% | $32.90K | AU$299.00B | 49.38% | 68 Neutral | |
| Hermes International | 2.84% | $31.78K | €171.93B | -32.48% | 79 Outperform |
PIEL Technical Analysis
Negative
―
Price Trends
28.69
Negative
27.23
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PIEL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 28.66, equal to the 50-day MA of 28.69, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PIEL.
PIEL Peer Comparison
Comparison Results
Performance Comparison
PIEL
Pacer International Export Leaders ETF
28.10
2.72
10.72%
AADR
AdvisorShares Dorsey Wright ADR ETF
―
―
―
PJIO
PGIM Jennison International Opportunities ETF
―
―
―
ESIM
Eventide International ETF
―
―
―
GIEQ
Goldman Sachs Data Enhanced International Equity ETF
―
―
―
VNIE
Vontobel International Equity Active ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents